STACI GUNTER: Open Payments
NPI 1003329962 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 18 payments from 12 companies in 2025. Trend: 2023 $16 · 2024 $450 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 3 | $59 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Astellas Pharma US Inc | 2 | $48 |
| ARRAY BIOPHARMA INC | 2 | $44 |
| ABBVIE INC. | 2 | $44 |
| SOBI, INC | 1 | $34 |
| GENZYME CORPORATION | 1 | $26 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
| Geron Corporation | 1 | $22 |
Products named: KEYTRUDA, Enhertu, LORBRENA, Doptelet, SARCLISA, EPKINLY, Padcev, NERLYNX.
Industry payments across UT — which companies pay providers there.
